# Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer

> **NCT07686016** · — · RECRUITING · sponsor: **Affidea Nu-med Center of Oncological DIagnostics and Therapy** · enrollment: 700 (estimated)

## Conditions studied

- Prostate Cancer
- Metastatic Prostate Cancer
- Oligometastatic Prostate Cancer
- Synchronous Oligometastatic Prostate Cancer

## Interventions

- **RADIATION:** Definitive Prostate-Directed Radiotherapy
- **RADIATION:** Metastasis-Directed Stereotactic Body Radiotherapy
- **RADIATION:** Pelvic Lymph Node Irradiation
- **RADIATION:** Prostate Brachytherapy

## Key facts

- **NCT ID:** NCT07686016
- **Lead sponsor:** Affidea Nu-med Center of Oncological DIagnostics and Therapy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-26
- **Primary completion:** 2028-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07686016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07686016, "Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07686016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*